Blue Water Vaccines Inc. Contracts & Agreements
108 Contracts & Agreements
- Business Finance (34 contracts)
- Business Operations (12)
- Human Resources (31)
- Intellectual Property (9)
- Real Estate (1)
- Uncategorized (21)
- ELOC Purchase Agreement dated October 2, 2024 (Filed With SEC on November 12, 2024)
- Form of Warrant (Filed With SEC on October 3, 2024)
- Form of Securities Purchase Agreement dated October 2, 2024 relating to the sale of the Series C Preferred Stock and Warrants (Filed With SEC on October 3, 2024)
- Form of Registration Rights Agreement dated as of October 2, 2024 relating to the resale of the shares of Common Stock underlying the Series C Preferred Stock and Warrants (Filed With SEC on October 3, 2024)
- Form of ELOC Purchase Agreement dated October 2, 2024 (Filed With SEC on October 3, 2024)
- Form of ELOC Registration Rights Agreement dated October 2, 2024 (Filed With SEC on October 3, 2024)
- Form of Altos Warrants (Filed With SEC on September 24, 2024)
- Amended and Restated Forbearance Agreement between the Company and Veru, dated September 19, 2024 (Filed With SEC on September 20, 2024)
- Form of Inducement PIO (Filed With SEC on July 11, 2024)
- Form of Inducement Letter (Filed With SEC on July 11, 2024)
- Consulting Agreement, dated June 10, 2024, between the Company and Karina Fedasz (Filed With SEC on June 14, 2024)
- Master Research Services Agreement, dated October 1, 2022, by and between Proteomedix AG and Immunovia, AB (Filed With SEC on June 5, 2024)
- Collaboration Agreement, dated July 19, 2021, by and between Proteomedix AG and New Horizon Health Limited (Filed With SEC on June 5, 2024)
- Amendment No. 1, dated June 26, 2023, to Collaboration Agreement, dated July 19, 2021, by and between Proteomedix AG and New Horizon Health Limited (Filed With SEC on June 5, 2024)
- Forbearance Agreement, dated April 24, 2024, between the Company and Veru (Filed With SEC on April 26, 2024)
- Amendment to Non-Convertible Debenture, dated April 24, 2024, between the Company and Altos (Filed With SEC on April 26, 2024)
- Description of Registered Securities (Filed With SEC on April 11, 2024)
- Form of Employment Agreement with Ralph Schiess (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement, dated October 15, 2020, by and between Proteomedix and Ralph Schiess (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement by and between Proteomedix and Ralph Schiess (Filed With SEC on April 11, 2024)
- Form of Employment Agreement with Christian Brhlmann (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement, dated October 16, 2020, by and between Proteomedix and Christian Brhlmann (Filed With SEC on April 11, 2024)
- Amendment to Employment Agreement by and between Proteomedix and Christian Brhlmann (Filed With SEC on April 11, 2024)
- License Agreement, dated March 27, 2023, between Proteomedix and Laboratory Corporation of America Holdings (Filed With SEC on April 11, 2024)
- Consulting Agreement, dated January 4, 2024 (Filed With SEC on February 12, 2024)
- Debenture, dated January 23, 2024 (Filed With SEC on January 29, 2024)
- Separation Agreement, dated January 17, 2024, between the Company and Erin Henderson (Filed With SEC on January 19, 2024)
- Consulting Agreement, dated January 17, 2024, between the Company and The Aetos Group (Filed With SEC on January 19, 2024)
- Share Exchange Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix AG, Thomas Meier and the Sellers (Filed With SEC on December 21, 2023)
- Certificate of Designation of Series B Convertible Preferred Stock (Filed With SEC on December 21, 2023)
- Form of Lock-Up Agreement, dated as of December 15, 2023, by and among Onconetix and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Non-Competition and Non-Solicitation Agreement, dated as of December 15, 2023, by and among Onconetix and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Stockholder Support Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and certain stockholders of Proteomedix (Filed With SEC on December 21, 2023)
- Form of Subscription Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and the Investor (Filed With SEC on December 21, 2023)
- Exclusive Distribution Agreement, dated September 20, 2023, between the Company and Cardinal Health 105, LLC (Filed With SEC on November 17, 2023)
- Form of Amendment, dated October 5, 2023, to Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue... (Filed With SEC on October 20, 2023)
- Employment Agreement, dated October 4, 2023, between the Company and Dr. Neil Campbell (Filed With SEC on October 10, 2023)
- Employment Agreement, dated October 4, 2023, between the Company and Bruce Harmon (Filed With SEC on October 10, 2023)
- Form of Indemnification Agreement (Filed With SEC on October 10, 2023)
- Amendment to Asset Purchase Agreement, dated as of September 29, 2023, by and between Blue Water Biotech, Inc. and Veru Inc (Filed With SEC on October 3, 2023)
- Form of Inducement PIO (Filed With SEC on August 3, 2023)
- Form of Letter Agreement (Filed With SEC on August 3, 2023)
- Form of Inducement PIO (Filed With SEC on August 1, 2023)
- Form of Inducement Letter (Filed With SEC on August 1, 2023)
- Asset Purchase Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, Legacy-Xspire Holdings, LLC and Blue Water Biotech, Inc (Filed With SEC on June 14, 2023)
- Management Services Agreement, dated June 13, 2023, by and among WraSer, LLC, Xspire Pharma, LLC, and Blue Water Biotech, Inc (Filed With SEC on June 14, 2023)
- Patent & Technology License Agreement, dated November 18, 2022, between the Company and the University of Texas Health Science Center at San Antonio (Filed With SEC on May 12, 2023)
- Co-Development Agreement, dated February 1, 2023, between the Company and AbVacc, Inc (Filed With SEC on May 12, 2023)
- Asset Purchase Agreement, dated as of April 19, 2023, between Veru Inc. and Blue Water Vaccines Inc (Filed With SEC on April 20, 2023)
- Form of Non-Competition and Non-Solicitation Agreement, dated as of April 19, 2023 (Filed With SEC on April 20, 2023)
- At-the-Market Offering Agreement, dated March 29, 2023 (Filed With SEC on March 29, 2023)
- Settlement Agreement and Release, dated October 9, 2022, by and between the Registrant and Boustead Securities, LLC (Filed With SEC on November 14, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on August 11, 2022)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on August 11, 2022)
- Form of Securities Purchase Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Form of Registration Rights Agreement, dated as of August 9, 2022, by and among the Company and the Purchasers (Filed With SEC on August 11, 2022)
- Sponsored Research Agreement, effective as of June 30, 2022, by and between Blue Water Vaccines Inc. and Childrens Hospital Medical Center, d/b/a Cincinatti Childrens Hospital... (Filed With SEC on July 25, 2022)
- Agreement for the Sponsorship of a Research Project, dated as of December 19, 2019, by and between Blue Water Vaccines Inc. and The Chancellor Masters and Scholars of the... (Filed With SEC on June 1, 2022)
- Amendment to Agreement for the Sponsorship of a Research Project, dated May 16, 2022 (Filed With SEC on June 1, 2022)
- Amendment No. 1 to Project Addendum 2 to Master Services Agreement, dated as of April 20, 2022, by and between the Registrant and Ology Bioservices, Inc (Filed With SEC on May 13, 2022)
- Amendment #1 to Exclusive License Agreement, dated as of May 11, 2022, by and between the Registrant and St. Jude Childrens Research Hospital, Inc (Filed With SEC on May 13, 2022)
- Form of Pre-Funded Common Stock Purchase Warrant, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Form of Preferred Investment Options, by and among the Company and the holders (Filed With SEC on April 19, 2022)
- Form of Wainwright Warrants by and among the Company and H.C. Wainwright & Co., LLC (Filed With SEC on April 19, 2022)
- Form of Securities Purchase Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Form of Registration Rights Agreement, dated as of April 13, 2022, by and among the Company and the Purchasers (Filed With SEC on April 19, 2022)
- Description of Registered Securities (Filed With SEC on March 31, 2022)
- Underwriting Agreement (Filed With SEC on February 24, 2022)
- Representatives Warrant (Filed With SEC on February 24, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 8, 2022)
- Form of Representatives Warrant (Filed With SEC on February 8, 2022)
- Form of Warrant (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Incentive Stock Option Agreement (Employee) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Consultant) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Non-Employee Director) (Filed With SEC on January 6, 2022)
- 2022 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Employee) (Filed With SEC on January 6, 2022)
- Form of Employment Agreement with Erin Henderson (Filed With SEC on January 6, 2022)
- Form of Employment Agreement with Jon Garfield (Filed With SEC on January 6, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on January 6, 2022)
- Form of Underwriting Agreement (Filed With SEC on December 29, 2021)
- Form of Representatives Warrant (included in Exhibit 1.1) (Filed With SEC on December 29, 2021)
- Form of Warrant (Filed With SEC on December 29, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on December 29, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 29, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 29, 2021)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 29, 2021)
- Form of Employment Agreement with Jon Garfield (Filed With SEC on November 29, 2021)
- Specimen Common Stock Certificate (Filed With SEC on November 5, 2021)
- Exclusive License Agreement between the Registrant and Childrens Hospital Medical Center, d/b/a Cincinnati Childrens Hospital Medical Center, effective as of June 1, 2021 (Filed With SEC on November 5, 2021)
- License Agreement between the Registrant and Oxford University Innovation Limited, effective as of July16, 2019 (Filed With SEC on November 5, 2021)
- Exclusive License Agreement between the Registrant and St. Jude Childrens Research Hospital, Inc., effective as of January 27, 2020 (Filed With SEC on November 5, 2021)
- 2019 Equity Incentive Plan (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan (Filed With SEC on October 8, 2021)
- 2019 Equity Incentive Plan Form of Stock Option Grant Agreement (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Incentive Stock Option Agreement (Employee) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Consultant) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Non-Employee Director) (Filed With SEC on October 8, 2021)
- 2021 Equity Incentive Plan Form of Nonstatuory Stock Option Agreeement (Employee) (Filed With SEC on October 8, 2021)
- Lease Agreement, dated as of April 29, 2021, between the Registrant and Regus Management Group, LLC (Filed With SEC on October 8, 2021)
- Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of July 19, 2019 (Filed With SEC on October 8, 2021)
- Project Addendum 1 to Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of October 9, 2019 (Filed With SEC on October 8, 2021)
- Letter Agreement between the Registrant and Ology Bioservices, Inc., dated as of January 9, 2020 (Filed With SEC on October 8, 2021)
- Project Addendum II to Master Services Agreement between the Registrant and Ology Bioservices, Inc., effective as of May 21, 2021 (Filed With SEC on October 8, 2021)
- Form of Employment Agreement with Joseph Hernandez (Filed With SEC on October 8, 2021)
- Form of Employment Agreement with Erin Henderson (Filed With SEC on October 8, 2021)
- Form of Indemnification Agreement for Directors and Officers (Filed With SEC on October 8, 2021)
